Efficacy and Safety of Adding Ribavirin to Sofosbuvir-Based Direct-Acting Antivirals (DAAs) in Re-Treating Non-Genotype 1 Hepatitis C-A Systematic Review and Meta-Analysis
在非基因1型肝炎再治疗中,利巴韦林联合索非布韦类直接抗病毒药物(DAA)的疗效和安全性:系统评价和荟萃分析
期刊:Diseases
影响因子:3
doi:10.3390/diseases13050138
Hamran, Shahd; Al-Rajhi, Amani A; Jasim, Kawthar; Al-Theyab, Majed A; Elahtam, Mohamed; Al-Hail, Mooza K; Al-Fahaidi, Wadha; Khamis, Yaman A; Dweidri, Yara; Elzouki, Abdel-Naser; Chivese, Tawanda